Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.06M |
|
$-3.21M |
|
$0.19M |
|
$-0.13M |
|
$3.21M |
|
$-3.15M |
|
$-0.06M |
|
$-3.21M |
|
$-3.21M |
|
$-3.21M |
|
$-3.21M |
|
$-3.21M |
|
$-3.21M |
|
$-3.15M |
|
$-2.93M |
|
12.20M |
|
12.20M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$6.75M |
|
$1.46M |
|
$4.04M |
|
$10.79M |
|
$2.67M |
|
-- |
|
$2.03M |
|
$4.70M |
|
$6.08M |
|
$6.01M |
|
$6.08M |
|
12.80M |
|
| Cash Flow Statement Financials | |
$-9.42M |
|
$-0.03M |
|
$3.10M |
|
$11.91M |
|
$5.59M |
|
$-6.32M |
|
$1.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.53 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-220.00% |
|
-5249.98% |
|
-5249.98% |
|
-- |
|
-5344.98% |
|
-5344.98% |
|
$-9.45M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.34 |
|
0.27 |
|
336.00 |
|
-52.74% |
|
-53.38% |
|
-29.74% |
|
-52.74% |
|
$0.47 |
|
$-0.77 |
|
$-0.77 |
|